Literature DB >> 11899298

Regulation of allergic airways inflammation by cytokines and glucocorticoids.

L Cameron1, Q Hamid.   

Abstract

Cytokines mediate the allergic inflammatory response of the airways, and glucocorticosteroids ameliorate allergy symptoms by regulating cytokine expression. Recent studies provide insight into the manner by which cytokines work together to mediate allergic airway disease. Real progress has also been gained in our understanding of subcellular mechanisms of allergic inflammation, particularly the role of transcription factors in regulating the expression of specific cytokine profiles and the differentiation of the TH2 subset. This article provides an update of recently reported findings in this field and highlights emerging concepts of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899298     DOI: 10.1007/s11882-001-0083-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  180 in total

Review 1.  Molecular pathology of allergic disease: I: lower airway disease.

Authors:  Q A Hamid; E M Minshall
Journal:  J Allergy Clin Immunol       Date:  2000-01       Impact factor: 10.793

2.  An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects.

Authors:  L J Wood; R Sehmi; G M Gauvreau; R M Watson; R Foley; J A Denburg; P M O'byrne
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

3.  Transcription mediated by NFAT is highly inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells.

Authors:  M Rincón; R A Flavell
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene.

Authors:  Z Song; V Casolaro; R Chen; S N Georas; D Monos; S J Ono
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

5.  Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis.

Authors:  E M Minshall; L Cameron; F Lavigne; D Y Leung; D Hamilos; E A Garcia-Zepada; M Rothenberg; A D Luster; Q Hamid
Journal:  Am J Respir Cell Mol Biol       Date:  1997-12       Impact factor: 6.914

6.  Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.

Authors:  M H Thornhill; S M Wellicome; D L Mahiouz; J S Lanchbury; U Kyan-Aung; D O Haskard
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

7.  Human T cell lines and clones respond to IL-9.

Authors:  F A Houssiau; J C Renauld; M Stevens; F Lehmann; B Lethe; P G Coulie; J Van Snick
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

8.  Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31.

Authors:  G Dolganov; S Bort; M Lovett; J Burr; L Schubert; D Short; M McGurn; C Gibson; D B Lewis
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

9.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment.

Authors:  S Ying; L Taborda-Barata; Q Meng; M Humbert; A B Kay
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  1 in total

1.  The glucocorticoid RU24858 does not distinguish between transrepression and transactivation in primary human eosinophils.

Authors:  Mirkka Janka-Junttila; Eeva Moilanen; Hannele Hasala; Xianzhi Zhang; Ian Adcock; Hannu Kankaanranta
Journal:  J Inflamm (Lond)       Date:  2006-07-12       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.